Australian Scientist Sees Skin Cancer Vaccine Within 10 Years
This article was originally published in PharmAsia News
An Australian scientist says he expects to have a skin cancer vaccine ready for the market in five to 10 years. Ian Frazer, credited with developing the vaccine against cervical cancer, said he believes the skin cancer vaccine he is developing could be given to children between the ages of 10 and 12 years old to protect them permanently against the cancer. Tests have been completed on animals, and human trials are expected to begin next year, he said. Australia and New Zealand have the highest rates of melanoma in the world. (Click here for more
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
BeiGene gets a new chief business executive and there are new CMOs at Cellectar Biopharma, MacroGenics and Reata Pharmaceuticals.
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.